Skip to main content
SpringerLink
Log in

Exposure to nitrosatable drugs may increase risk of stillbirth

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Thomsen AML, et al. Nitrosatable drug exposure during pregnancy and risk of stillbirth. Pharmacoepidemiology and Drug Safety : 26 Jul 2019. Available from: URL: http://doi.org/10.1002/pds.4867

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Exposure to nitrosatable drugs may increase risk of stillbirth. Reactions Weekly 1765, 6 (2019). https://doi.org/10.1007/s40278-019-65763-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-65763-7

Search

Navigation